The Effect of Low-Frequency Repetitive Transcranial Magnetic Stimulation (rTMS) in Stroke Patients
Launched by ANKARA CITY HOSPITAL BILKENT · Mar 17, 2025
Trial Information
Current as of April 22, 2025
Completed
Keywords
ClinConnect Summary
Post-stroke spasticity is a common complication that can severely impact daily living activities, causing pain and hygiene challenges for a significant number of patients. Spasticity is a clinical condition that arises as a result of abnormal or hyperexcitable spinal reflexes, and the excitability of the spinal stretch reflex is regulated through supraspinal descending pathways such as the Dorsal Reticulospinal tract, Medial Reticulospinal tract, and Vestibulospinal tract. The treatment of spasticity can be categorized into non-pharmacological, pharmacological, and surgical approaches. Phar...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Having a lesion in a single hemisphere confirmed by MRI,
- • At least 6 months and at most 2 years having passed since the stroke,
- • Spasticity in wrist flexors and finger flexors at levels 1+, 2, or 3 according to the modified Ashworth scale,
- • Being between 18-75 years old,
- • Having a Mini-Mental Test score of ≥ 24,
- • If using antispastic medication, no change in medication dosage in the last month.
- Exclusion Criteria:
- • History of epilepsy, dementia, cognitive impairment, or neurodegenerative disease,
- • Having a metallic materials in the area to be stimulated (such as a cochlear implant, brain pacemaker, or drug pump),
- • Alcoholism,
- • Pregnancy,
- • Severe and newly decompensated heart failure,
- • Using medications that lower the seizure threshold.
Trial Officials
Elif Yalçın, Prof, MD
Study Chair
Ankara City Hospital Bilkent
About Ankara City Hospital Bilkent
Ankara City Hospital Bilkent is a leading healthcare institution in Turkey, dedicated to advancing medical research and improving patient outcomes through innovative clinical trials. Equipped with state-of-the-art facilities and a multidisciplinary team of experienced professionals, the hospital fosters a collaborative environment for conducting rigorous scientific investigations. Its commitment to ethical standards and patient safety ensures that all clinical trials are conducted with the highest level of integrity, ultimately contributing to the development of new therapies and enhancing the quality of care provided to patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ankara, , Turkey
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported